Helmut Petto

1.3k total citations
29 papers, 759 citations indexed

About

Helmut Petto is a scholar working on Orthopedics and Sports Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Helmut Petto has authored 29 papers receiving a total of 759 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Orthopedics and Sports Medicine, 10 papers in Oncology and 8 papers in Molecular Biology. Recurrent topics in Helmut Petto's work include Bone health and osteoporosis research (14 papers), Bone health and treatments (10 papers) and Bone Metabolism and Diseases (6 papers). Helmut Petto is often cited by papers focused on Bone health and osteoporosis research (14 papers), Bone health and treatments (10 papers) and Bone Metabolism and Diseases (6 papers). Helmut Petto collaborates with scholars based in United States, United Kingdom and France. Helmut Petto's co-authors include J Štěpán, Imre Pávó, Harald Dobnig, Astrid Fahrleitner‐Pammer, David B. Burr, Dana Michalská, Jiliang Li, Adrien Sipos, Fernando Marín and Fernando Marín and has published in prestigious journals such as Diabetes Care, Journal of Bone and Joint Surgery and Journal of Bone and Mineral Research.

In The Last Decade

Helmut Petto

28 papers receiving 735 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Helmut Petto United States	17	430	300	195	189	112	29	759
K Hoszowski Belgium	5	477 1.1×	248 0.8×	197 1.0×	222 1.2×	212 1.9×	14	844
Martha C. Castaño‐Betancourt Netherlands	10	306 0.7×	137 0.5×	159 0.8×	210 1.1×	60 0.5×	16	636
S. Gonnelli Italy	13	414 1.0×	236 0.8×	206 1.1×	112 0.6×	81 0.7×	18	738
Elisabeth Zwettler Austria	16	336 0.8×	182 0.6×	166 0.9×	361 1.9×	41 0.4×	28	758
Tuan V. Nguyen Australia	11	410 1.0×	172 0.6×	318 1.6×	227 1.2×	87 0.8×	12	967
S. T. Harris United States	10	436 1.0×	182 0.6×	173 0.9×	218 1.2×	88 0.8×	22	775
R Willvonseder Austria	19	403 0.9×	242 0.8×	272 1.4×	156 0.8×	86 0.8×	57	863
Albrecht W. Popp Switzerland	18	550 1.3×	306 1.0×	199 1.0×	289 1.5×	25 0.2×	33	891
Hideaki Kishimoto Japan	16	827 1.9×	539 1.8×	327 1.7×	301 1.6×	60 0.5×	33	1.2k
Vanadin Seifert‐Klauss Germany	15	261 0.6×	99 0.3×	145 0.7×	97 0.5×	155 1.4×	59	777

Countries citing papers authored by Helmut Petto

Since Specialization

Citations

This map shows the geographic impact of Helmut Petto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helmut Petto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helmut Petto more than expected).

Fields of papers citing papers by Helmut Petto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Helmut Petto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helmut Petto. The network helps show where Helmut Petto may publish in the future.

Co-authorship network of co-authors of Helmut Petto

This figure shows the co-authorship network connecting the top 25 collaborators of Helmut Petto. A scholar is included among the top collaborators of Helmut Petto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Helmut Petto. Helmut Petto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bruin‐Weller, Marjolein de, E. Serra‐Baldrich, S. Barbarot, et al.. (2022). Indirect Treatment Comparison of Baricitinib versus Dupilumab in Adults with Moderate-to-Severe Atopic Dermatitis. Dermatology and Therapy. 12(6). 1481–1491. 9 indexed citations

Petto, Helmut, Zbigniew Kadziola, Alan Brnabic, Daniel Saure, & Mark Belger. (2018). Alternative Weighting Approaches for Anchored Matching-Adjusted Indirect Comparisons via a Common Comparator. Value in Health. 22(1). 85–91. 24 indexed citations

Napoli, Nicola, Bente Langdahl, Östen Ljunggren, et al.. (2018). Effects of Teriparatide in Patients with Osteoporosis in Clinical Practice: 42-Month Results During and After Discontinuation of Treatment from the European Extended Forsteo® Observational Study (ExFOS). Calcified Tissue International. 103(4). 359–371. 29 indexed citations

Petto, Helmut, Ulrich Mrowietz, Stefan Wilhelm, & Alexander Schacht. (2018). A statistical method to convert published response rates into marginal distributions with an example application in psoriasis. Pharmaceutical Statistics. 18(1). 4–21. 1 indexed citations

Fahrleitner‐Pammer, Astrid, David B. Burr, Harald Dobnig, et al.. (2016). Improvement of cancellous bone microstructure in patients on teriparatide following alendronate pretreatment. Bone. 89. 16–24. 16 indexed citations

Malouf, Jorge, Umberto Tarantino, Pedro Alberto García-Hernández, et al.. (2016). Effect of Teriparatide or Risedronate in Elderly Patients With a Recent Pertrochanteric Hip Fracture: Final Results of a 78-Week Randomized Clinical Trial. Journal of Bone and Mineral Research. 32(5). 1040–1051. 35 indexed citations

Aspenberg, Per, Jorge Malouf, Umberto Tarantino, et al.. (2016). Effects of Teriparatide Compared with Risedronate on Recovery After Pertrochanteric Hip Fracture. Journal of Bone and Joint Surgery. 98(22). 1868–1878. 43 indexed citations

Belger, Mark, Alan Brnabic, Zbigniew Kadziola, Helmut Petto, & D Faries. (2015). Alternative Weighting Approaches For Matching Adjusted Indirect Comparisons (Maic). Value in Health. 18(3). A31–A32. 6 indexed citations

Belger, Mark, Alan Brnabic, Zbigniew Kadziola, Helmut Petto, & D Faries. (2015). Inclusion Of Multiple Studies In Matching Adjusted Indirect Comparisons (Maic). Value in Health. 18(3). A33–A33. 7 indexed citations

10.

Marchettini, Paolo, Stefan Wilhelm, Helmut Petto, et al.. (2015). Are there different predictors of analgesic response between antidepressants and anticonvulsants in painful diabetic neuropathy?. European Journal of Pain. 20(3). 472–482. 28 indexed citations

11.

Ljunggren, Östen, Claude Laurent Benhamou, Joost Dekker, et al.. (2014). Study description and baseline characteristics of the population enrolled in a multinational observational study of extended teriparatide use (ExFOS). Current Medical Research and Opinion. 30(8). 1607–1616. 13 indexed citations

12.

Gamsjaeger, Sonja, Franz Varga, Harald Dobnig, et al.. (2014). Bone quality of the newest bone formed after two years of teriparatide therapy in patients who were previously treatment-naïve or on long-term alendronate therapy. Osteoporosis International. 25(12). 2709–2719. 17 indexed citations

13.

Vázquez, Luis Alberto, Ángel Rodríguez, Javier Salvador, et al.. (2014). Relationships between obesity, glycemic control, and cardiovascular risk factors: a pooled analysis of cross-sectional data from Spanish patients with type 2 diabetes in the preinsulin stage. BMC Cardiovascular Disorders. 14(1). 153–153. 23 indexed citations

14.

Rajzbaum, Gérald, Franck Grados, David Evans, et al.. (2013). Treatment persistence and changes in fracture risk, back pain, and quality of life amongst patients treated with teriparatide in routine clinical care in France: Results from the European Forsteo Observational Study. Joint Bone Spine. 81(1). 69–75. 29 indexed citations

15.

Graeff, Christian, Fernando Marín, Helmut Petto, et al.. (2012). High resolution quantitative computed tomography-based assessment of trabecular microstructure and strength estimates by finite-element analysis of the spine, but not DXA, reflects vertebral fracture status in men with glucocorticoid-induced osteoporosis. Bone. 52(2). 568–577. 90 indexed citations

16.

Matthäei, S., Matthew Reaney, Chantal Mathieu, et al.. (2012). Patients with Type 2 Diabetes Initiating Exenatide Twice Daily or Insulin in Clinical Practice: CHOICE Study. Diabetes Therapy. 3(1). 6–6. 6 indexed citations

17.

Gallwitz, Baptist, Thomas Segiet, K Milek, et al.. (2011). Exenatide Twice Daily Versus Premixed Insulin Aspart 70/30 in Metformin-Treated Patients With Type 2 Diabetes. Diabetes Care. 34(3). 604–606. 76 indexed citations

18.

Dobnig, Harald, J Štěpán, David B. Burr, et al.. (2009). Teriparatide Reduces Bone Microdamage Accumulation in Postmenopausal Women Previously Treated With Alendronate. Journal of Bone and Mineral Research. 24(12). 1998–2006. 48 indexed citations

19.

Štěpán, J, David B. Burr, Imre Pávó, et al.. (2007). Low bone mineral density is associated with bone microdamage accumulation in postmenopausal women with osteoporosis. Bone. 41(3). 378–385. 114 indexed citations

20.

Ringe, J. D., George Christodoulakos, Dan Mellström, et al.. (2007). Patient compliance with alendronate, risedronate and raloxifene for the treatment of osteoporosis in postmenopausal women. Current Medical Research and Opinion. 23(11). 2677–2687. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact